194 related articles for article (PubMed ID: 22959804)
21. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
Angelini A; Di Pietro R; Centurione L; Castellani ML; Conti P; Porreca E; Cuccurullo F
J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269
[TBL] [Abstract][Full Text] [Related]
22. 5-aminolevulinic acid mediated photodynamic therapy inhibits survival activity and promotes apoptosis of A375 and A431 cells.
Cai J; Zheng Q; Huang H; Li B
Photodiagnosis Photodyn Ther; 2018 Mar; 21():257-262. PubMed ID: 29309850
[TBL] [Abstract][Full Text] [Related]
23. Potential therapeutic efficacy of photodynamic therapy on female hormonal-dependent cancers in a hormonal simulated microenvironment.
Chu ES; Wu RW; Huang Z
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103998. PubMed ID: 38316340
[TBL] [Abstract][Full Text] [Related]
24. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy.
Casas A; Fukuda H; Di Venosa G; Batlle A
Br J Cancer; 2001 Jul; 85(2):279-84. PubMed ID: 11461090
[TBL] [Abstract][Full Text] [Related]
25. Effect of photodynamic therapy with 5-aminolevulinic acid on human gastric cancer cells in vitro.
Huang ZH; Zhou GJ; Yu JL; Li Z; Ding LS; Xu RX; Jiang XD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):255-7. PubMed ID: 16546720
[TBL] [Abstract][Full Text] [Related]
26. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
Hua J; Mutch DG; Herzog TJ
Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
[TBL] [Abstract][Full Text] [Related]
27. Thioredoxin upregulation by 5-aminolaevulinic acid-based photodynamic therapy in human skin squamous cell carcinoma cell line.
Kuhara T; Watanabe D; Akita Y; Takeo T; Ishida N; Nakano A; Yamashita N; Ohshima Y; Kawada M; Yanagishita T; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):142-6. PubMed ID: 18477133
[TBL] [Abstract][Full Text] [Related]
28. Topical aminolaevulinic acid-photodynamic therapy produces an inflammatory infiltrate but reduces Langerhans cells in healthy human skin in vivo.
Evangelou G; Farrar MD; White RD; Sorefan NB; Wright KP; McLean K; Andrew S; Watson RE; Rhodes LE
Br J Dermatol; 2011 Sep; 165(3):513-9. PubMed ID: 21623750
[TBL] [Abstract][Full Text] [Related]
29. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells.
Gándara L; Sandes E; Di Venosa G; Prack Mc Cormick B; Rodriguez L; Mamone L; Batlle A; Eiján AM; Casas A
J Photochem Photobiol B; 2014 Apr; 133():55-64. PubMed ID: 24705371
[TBL] [Abstract][Full Text] [Related]
30. [Effect of 5-aminolevulinic acid-mediated photodynamic therapy on human gastric cancer xenografts in nude mice in vivo].
Zhou GJ; Huang ZH; Yu JL; Li Z; Ding LS
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Nov; 11(6):580-3. PubMed ID: 19031141
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of conditioned media derived from murine MSCs and 5-aminolevulinic acid (5-ALA) mediated photodynamic therapy in breast cancer in vitro.
Mohammadpour H; Majidzadeh-A K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):238-43. PubMed ID: 25721458
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of normal and malignant human lymphocytes to 5-aminolevulinic acid-mediated photodynamic damage.
Gamaleia NF; Shishko ED; Gluzman DF; Sklyarenko LM
Exp Oncol; 2008 Mar; 30(1):65-9. PubMed ID: 18438344
[TBL] [Abstract][Full Text] [Related]
34. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.
Chang CC; Huang LH; Chiang W; Hsia SM
Phytomedicine; 2018 Aug; 47():69-80. PubMed ID: 30166110
[TBL] [Abstract][Full Text] [Related]
35. Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer.
Chen X; Zhao P; Chen F; Li L; Luo R
Lasers Med Sci; 2011 Jan; 26(1):69-78. PubMed ID: 20676910
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
[TBL] [Abstract][Full Text] [Related]
37. Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells.
Chung CW; Kim CH; Lee HM; Kim DH; Kwak TW; Chung KD; Jeong YI; Kang DH
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):503-10. PubMed ID: 23429232
[TBL] [Abstract][Full Text] [Related]
38. Study of the efficacy and mechanism of ALA-mediated photodynamic therapy on human hepatocellular carcinoma cell.
Yow CM; Wong CK; Huang Z; Ho RJ
Liver Int; 2007 Mar; 27(2):201-8. PubMed ID: 17311614
[TBL] [Abstract][Full Text] [Related]
39. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy.
Coupienne I; Bontems S; Dewaele M; Rubio N; Habraken Y; Fulda S; Agostinis P; Piette J
Biochem Pharmacol; 2011 Mar; 81(5):606-16. PubMed ID: 21182827
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy.
Shinohara Y; Endo Y; Abe C; Shiba I; Ishizuka M; Tanaka T; Yonemura Y; Ogura SI; Tominaga M; Yamada H; Uto Y
Photodiagnosis Photodyn Ther; 2017 Dec; 20():182-188. PubMed ID: 29056554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]